• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Transcatheter arterial embolization in unresectable hepatocellular carcinoma.

作者信息

Yamada R, Kishi K, Sonomura T, Tsuda M, Nomura S, Satoh M

机构信息

Department of Radiology, Wakayama Medical College, Japan.

出版信息

Cardiovasc Intervent Radiol. 1990 Jun-Jul;13(3):135-9. doi: 10.1007/BF02575464.

DOI:10.1007/BF02575464
PMID:2171771
Abstract

Seven hundred thirty-nine patients with unresectable hepatocellular carcinoma have been treated by transcatheter arterial chemoembolization using gelatin sponge particles soaked in a solution of Mitomycin C and Adriamycin. This therapy can be equal or superior to surgical resection and serves both as embolic therapy and targeted chemotherapy.

摘要

相似文献

1
Transcatheter arterial embolization in unresectable hepatocellular carcinoma.
Cardiovasc Intervent Radiol. 1990 Jun-Jul;13(3):135-9. doi: 10.1007/BF02575464.
2
[The role of antineoplastic solution in transcatheter hepatic arterial embolization--in terms of survival rates affecting anticancer agents together with gelatin sponge].
Gan To Kagaku Ryoho. 1988 Aug;15(8 Pt 2):2621-6.
3
[Transcatheter hepatic artery infusion chemotherapy and embolization for 60 patients with primary hepatic carcinoma].经导管肝动脉灌注化疗及栓塞治疗60例原发性肝癌
Zhonghua Zhong Liu Za Zhi. 1991 Jan;13(1):33-6.
4
Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.肝细胞癌的肝动脉化疗栓塞术：不同栓塞剂的生存率比较
J Vasc Interv Radiol. 2005 Dec;16(12):1661-6. doi: 10.1097/01.RVI.0000182160.26798.A2.
5
[Ruptured hepatocellular carcinoma following transcatheter arterial embolization: a case report].经导管动脉栓塞术后肝细胞癌破裂：一例报告
Rinsho Hoshasen. 1986 Sep;31(9):1053-5.
6
Recurrent hepatocellular carcinoma after partial hepatectomy: value of treatment with transcatheter arterial chemoembolization.肝部分切除术后复发性肝细胞癌：经动脉化疗栓塞治疗的价值
AJR Am J Roentgenol. 1991 Jun;156(6):1177-9. doi: 10.2214/ajr.156.6.1851379.
7
[Transarterial chemoembolization therapy of hepatocellular carcinoma using anticancer agents (mitomycin C and/or adriamycin) suspended in lipiodol].
Nihon Igaku Hoshasen Gakkai Zasshi. 1985 Nov 25;45(11):1430-40.
8
[One-shot therapy and transcatheter arterial embolization (TAE) therapy of unresectable hepatocellular carcinoma].
Gan To Kagaku Ryoho. 1985 Oct;12(10):1930-7.
9
[Therapy of hepatic carcinoma by the intra-arterial injection of lipiodol, antineoplastic agents and gelfoam].
Radiol Med. 1989 Jan-Feb;77(1-2):37-43.
10
Transcatheter arterial chemoembolization with anticancer drug in iodized oil for primary hepatic carcinoma.经导管动脉化疗栓塞术联合碘油中抗癌药物治疗原发性肝癌。
Cardiovasc Intervent Radiol. 1989 Jul-Aug;12(4):181-7. doi: 10.1007/BF02577150.

引用本文的文献

1
Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis.口服支链氨基酸补充剂对接受肝细胞癌干预患者的疗效和安全性：一项荟萃分析。
Nutr J. 2015 Jul 9;14:67. doi: 10.1186/s12937-015-0056-6.
2
131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma.131I 标记的美妥昔单抗联合化疗栓塞治疗不可切除的肝细胞癌。
World J Gastroenterol. 2013 Dec 21;19(47):9104-10. doi: 10.3748/wjg.v19.i47.9104.
3
Reduction in non-protein respiratory quotient is related to overall survival after hepatocellular carcinoma treatment.

本文引用的文献

1
Hepatic artery embolization in the treatment of hepatic neoplasms.肝动脉栓塞术治疗肝脏肿瘤
Radiology. 1981 Jul;140(1):51-8. doi: 10.1148/radiology.140.1.7244243.
2
Ethanol for hepatic artery embolization.用于肝动脉栓塞的乙醇
Radiology. 1984 Sep;152(3):821-2. doi: 10.1148/radiology.152.3.6463268.
3
Regional chemotherapy of neoplastic diseases.肿瘤疾病的区域化疗。
非蛋白呼吸商降低与肝癌治疗后的总生存期相关。
PLoS One. 2013;8(3):e55441. doi: 10.1371/journal.pone.0055441. Epub 2013 Mar 8.
4
Preparation and characterization of gelatin sponge millispheres injectable through microcatheters.
Med Devices (Auckl). 2009;2:19-25. doi: 10.2147/mder.s4798. Epub 2009 Jan 21.
5
A high value of serum des-γ-carboxy prothrombin before hepatocellular carcinoma treatment can be associated with long-term liver dysfunction after treatment.肝癌治疗前血清去γ-羧基凝血酶原值高与治疗后长期肝功能障碍有关。
J Gastroenterol. 2012 Oct;47(10):1134-42. doi: 10.1007/s00535-012-0577-0. Epub 2012 Mar 24.
6
Short-term reductions in non-protein respiratory quotient and prealbumin can be associated with the long-term deterioration of liver function after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.短期非蛋白呼吸商和前白蛋白的降低可能与肝细胞癌患者经导管动脉化疗栓塞后肝功能的长期恶化有关。
J Gastroenterol. 2012 Jun;47(6):704-14. doi: 10.1007/s00535-012-0535-x. Epub 2012 Feb 18.
7
Preparation and characterization of gelatin sponge millispheres from air-in-water-in-oil-type emulsions.由水包油包气型乳液制备明胶海绵微球及其表征
J Mater Sci Mater Med. 2009 Jun;20(6):1299-305. doi: 10.1007/s10856-008-3681-1. Epub 2009 Jan 10.
8
Multivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization.经动脉化疗栓塞治疗肝细胞癌患者生存预测因素的多变量分析：聚焦于超选择性化疗栓塞
Korean J Radiol. 2008 Nov-Dec;9(6):534-40. doi: 10.3348/kjr.2008.9.6.534.
9
Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: risk estimates based on multiple prognostic factors.肝段动脉化疗栓塞术后肝细胞癌的局部复发：基于多种预后因素的风险评估
Korean J Radiol. 2007 Mar-Apr;8(2):111-9. doi: 10.3348/kjr.2007.8.2.111.
10
Risk factors for local tumor recurrence after segmental transarterial chemoembolization for hepatocellular carcinoma: the importance of tumor located in the segmental border zone.肝细胞癌节段性经动脉化疗栓塞术后局部肿瘤复发的危险因素：肿瘤位于节段边界区的重要性
Korean J Radiol. 2006 Oct-Dec;7(4):267-74. doi: 10.3348/kjr.2006.7.4.267.
Pharmacol Ther. 1983;21(2):277-93. doi: 10.1016/0163-7258(83)90077-3.
4
Hepatocellular carcinoma treated by transcatheter arterial embolization: progress evaluated by computed tomography.经导管动脉栓塞治疗肝细胞癌：通过计算机断层扫描评估进展情况
Radiology. 1984 Mar;150(3):773-8. doi: 10.1148/radiology.150.3.6320258.
5
Hepatic arterial embolization for hepatocellular carcinoma. Comparison of CT scans and resected specimens.
Radiology. 1984 Mar;150(3):661-5. doi: 10.1148/radiology.150.3.6320253.
6
Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report.动脉内注射高分子抗癌剂丝裂霉素与脂质淋巴造影剂联合应用对肝癌的影响：初步报告
Eur J Cancer Clin Oncol. 1983 Aug;19(8):1053-65. doi: 10.1016/0277-5379(83)90028-7.
7
Gallbladder infarction following hepatic transcatheter arterial embolization. Angiographic study.肝动脉导管栓塞术后胆囊梗死。血管造影研究。
Radiology. 1983 Oct;149(1):85-9. doi: 10.1148/radiology.149.1.6310685.
8
Hepatic artery embolization in 120 patients with unresectable hepatoma.120例不可切除肝癌患者的肝动脉栓塞术
Radiology. 1983 Aug;148(2):397-401. doi: 10.1148/radiology.148.2.6306721.
9
Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization.肝细胞癌的经导管栓塞术：栓塞后切除病例的疗效评估
Radiology. 1983 May;147(2):401-5. doi: 10.1148/radiology.147.2.6300959.
10
[Experimental and clinical studies on hepatic artery embolization for the treatment of hepatoma].肝动脉栓塞治疗肝癌的实验与临床研究
Nihon Igaku Hoshasen Gakkai Zasshi. 1983 Aug 25;43(8):977-1005.